NO992062L - Preparat for behandling av astma, inneholdende loratadin og et dekongestionsmiddel - Google Patents

Preparat for behandling av astma, inneholdende loratadin og et dekongestionsmiddel

Info

Publication number
NO992062L
NO992062L NO992062A NO992062A NO992062L NO 992062 L NO992062 L NO 992062L NO 992062 A NO992062 A NO 992062A NO 992062 A NO992062 A NO 992062A NO 992062 L NO992062 L NO 992062L
Authority
NO
Norway
Prior art keywords
asthma
decongestant
preparation
treatment
containing loratadine
Prior art date
Application number
NO992062A
Other languages
English (en)
Norwegian (no)
Other versions
NO992062D0 (no
Inventor
Alan G Harris
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO992062D0 publication Critical patent/NO992062D0/no
Publication of NO992062L publication Critical patent/NO992062L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO992062A 1996-10-31 1999-04-29 Preparat for behandling av astma, inneholdende loratadin og et dekongestionsmiddel NO992062L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73966996A 1996-10-31 1996-10-31
PCT/US1997/019158 WO1998018470A1 (en) 1996-10-31 1997-10-29 Composition, for the treatment of asthma, containing loratadine and a decongestant

Publications (2)

Publication Number Publication Date
NO992062D0 NO992062D0 (no) 1999-04-29
NO992062L true NO992062L (no) 1999-04-29

Family

ID=24973307

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992062A NO992062L (no) 1996-10-31 1999-04-29 Preparat for behandling av astma, inneholdende loratadin og et dekongestionsmiddel

Country Status (21)

Country Link
EP (1) EP0941091A1 (sk)
JP (1) JP2000505104A (sk)
KR (1) KR20000052922A (sk)
CN (1) CN1235545A (sk)
AR (1) AR008908A1 (sk)
AU (1) AU731756B2 (sk)
BR (1) BR9712705A (sk)
CA (1) CA2268546A1 (sk)
CO (1) CO4910128A1 (sk)
CZ (1) CZ150999A3 (sk)
HU (1) HUP9904075A3 (sk)
ID (1) ID23431A (sk)
IL (1) IL129662A0 (sk)
NO (1) NO992062L (sk)
NZ (1) NZ335078A (sk)
PE (1) PE11399A1 (sk)
PL (1) PL333056A1 (sk)
SK (1) SK54599A3 (sk)
TR (1) TR199901003T2 (sk)
WO (1) WO1998018470A1 (sk)
ZA (1) ZA979731B (sk)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999021556A1 (en) * 1997-10-29 1999-05-06 J-Med Pharmaceuticals, Inc. Antihistamine/decongestant regimens for treating rhinitis
US6132758A (en) 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
IT1303671B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
PE20001070A1 (es) * 1998-09-10 2000-10-19 Schering Corp Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando antihistaminas
US6521254B2 (en) 1998-12-07 2003-02-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
AU2697100A (en) * 1999-02-23 2000-09-14 Yuhan Corporation Pharmaceutical capsule compositions containing loratadine and pseudoephedrine
KR100505899B1 (ko) * 1999-02-23 2005-08-01 주식회사유한양행 로라타딘과 슈도에페드린을 함유한 캅셀제 조성물
AU3924500A (en) * 1999-03-29 2000-10-16 Schering Corporation Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine
WO2001045668A2 (en) * 1999-12-20 2001-06-28 Schering Corporation Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
AU2276801A (en) * 1999-12-20 2001-07-03 Schering Corporation Extended release oral dosage composition
WO2001078782A1 (en) * 2000-04-14 2001-10-25 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
PE20020055A1 (es) * 2000-05-25 2002-02-12 Schering Corp Formulaciones estables liquidas y solidas que comprenden una antihistamina no sedante y un descongestionante nasal
WO2003000264A1 (en) * 2001-06-20 2003-01-03 Schering Corporation Antihistamines for the treatment of nasal congestion and nasal obstruction
AU2005333081B2 (en) 2005-06-17 2010-06-24 Aft Pharmaceuticals Limited Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion
EP2034970B1 (en) * 2006-06-01 2012-08-01 MSD Consumer Care, Inc. Sustained release pharmaceutical formulation comprising phenylephrine
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
KR101540191B1 (ko) * 2014-02-24 2015-07-28 성균관대학교산학협력단 로라타딘을 포함하는 항염증용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1110397A (en) * 1964-10-02 1968-04-18 Mead Johnson & Co Ephedrine composition
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5314697A (en) * 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine

Also Published As

Publication number Publication date
BR9712705A (pt) 1999-10-26
WO1998018470A1 (en) 1998-05-07
AR008908A1 (es) 2000-02-23
NZ335078A (en) 2000-10-27
CA2268546A1 (en) 1998-05-07
NO992062D0 (no) 1999-04-29
HUP9904075A2 (hu) 2000-05-28
CZ150999A3 (cs) 1999-10-13
IL129662A0 (en) 2000-02-29
CN1235545A (zh) 1999-11-17
TR199901003T2 (xx) 1999-07-21
ID23431A (id) 2000-04-20
SK54599A3 (en) 2000-08-14
PE11399A1 (es) 1999-02-09
ZA979731B (en) 1998-04-29
JP2000505104A (ja) 2000-04-25
AU731756B2 (en) 2001-04-05
EP0941091A1 (en) 1999-09-15
PL333056A1 (en) 1999-11-08
HUP9904075A3 (en) 2002-02-28
KR20000052922A (ko) 2000-08-25
AU4995397A (en) 1998-05-22
CO4910128A1 (es) 2000-04-24

Similar Documents

Publication Publication Date Title
NO992062L (no) Preparat for behandling av astma, inneholdende loratadin og et dekongestionsmiddel
NO985464L (no) Konsentrert antistoffpreparat
NO972475L (no) Ny antitrombotisk formulering, fremgangsmåte for dens fremstilling og anvendelse derav
IS2788B (is) Búdesóníð- / formóterólefnablanda til innöndunar með lausa þéttni frá 0,30 til 0,36 g/ml, aðferð við að framleiða efnablönduna og notkun hennar
MX9706785A (es) Formas de dosificacion farmaceutica oral que comprenden un inhibidor de la bomba de protones y un agente antiacido o alginato.
NO983641L (no) Fremgangsmåte til behandling og farmasöytisk preparat
NO972780D0 (no) Inhalasjonsanordning, fremgangsmåte for fordeling av et farmasöytisk aktivt stoff og fremgangsmåte for administrering av en dose med et farmasöytisk aktivt stoff
TW329387B (en) Pharmaceutical composition for treating airway passage and lung diseases comprising mometasone furoate
NO20010844L (no) Regulering av substrataktivitet
NO20040968L (no) Opioidagonistpreparater med frigjorbar og sekvestrert antagonist
NO993847L (no) FremgangsmÕter og preparater for behandling av allergisk astma og andre sykdommer ved anvendelse av deskarboetoksyloratadin
EE04800B1 (et) Oraalne manustamisvorm happes ebapüsiva toimeainetarbeks, toimeaineühik, selle valmistamismeetod ja kasutamine ning meetod oraalse manustamisvormi valmistamiseks
AU2002224914A1 (en) Method and device for the diagnosis and therapy of chronic heart failure
NO308854B1 (no) Terapeutiske forbindelser, farmasøytisk akseptable salter og formuleringer inneholdende forbindelsene, samt anvendelser derav
NO20015931L (no) Farmasöytiske formuleringer og fremgangsmåter som omfatter intranasal morfin
DE60128912D1 (en) Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
ITRM920412A0 (it) Eteroprostanoidi, procedimento per la loro preparazione e loro impiegoterapeutico.
WO1998020869A3 (en) Formulation for electrically assisted delivery of lidocaine and epinephrine
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
BR0213293A (pt) Uso de tfpi ou de um análogo de tfpi no tratamento de septicemia
SE9603725D0 (sv) New teatment
NO20101070L (no) Fremgangsmate til dosering av et medikament, samt doseringsform
NO20000293L (no) Preparater, kits og fremgangsmõter for inhibering av cerebrale neurovaskulære forstyrrelser og muskulære hodepiner
NO943288L (no) Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer
NO984446L (no) FremgangsmÕte for behandling av smerte

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application